Evaluating only Diabetio’s profile at its peak — without knowing the outcome — the model ranked Regulation as the #1 likely cause. That’s exactly how it died.
Key Events Timeline
FOUNDING
Diabetio founded in Budapest to help Hungarian diabetes patients track glucose, medication and diet.
FUNDING
€800K raised from Day One Capital; Rossmann pharmacy chain partnership announced.
REGULATORY ACTION
NEAK denies medical device classification, blocking insurance reimbursement for the app.
SHUTDOWN
Company winds down after user retention collapses without insurance coverage pathway.
Full Analysis
Free · no account needed
Documented cause
Hungarian diabetes management app Diabetio raised €800K from Day One Capital and Hungarian angels to compete with MySugr. Despite 15,000 app downloads and a partnership with Hungarian pharmacy chain Rossmann, the startup could not secure reimbursement from the National Health Insurance Fund (NEAK), which refused to classify the app as a medical device. Without insurance coverage, user retention collapsed and the company wound down quietly in 2020.
Lesson
“Digital health startups in CEE must map insurance reimbursement pathways before building, not after launching.”